TelyRx Holdings Inc. experienced a notable surge in its stock price, reflecting growing investor confidence.
TelyRx Holdings Inc. saw its stock price increase by an impressive 13.04% in yesterday's trading session, closing at CA$2.60. This significant gain highlights the market's positive sentiment towards the company, which has been making strides in the digital pharmacy sector.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$61.13M
52W high
$4.25
52W low
$2.00
1W change
-7.96%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 130.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+130.8% Upside
Current Price
C$2.60
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
106.2%
Annualized
90-Day Vol
102.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.17
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.45 | C$1.70 – C$3.53 |
| 60 trading days | C$2.31 | C$1.37 – C$3.88 |
| 90 trading days | C$2.17 | C$1.15 – C$4.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may want to keep an eye on TelyRx, as its recent performance suggests a growing interest in its services and potential for future growth.
TelyRx Holdings Inc. stock jumps 13.04%
The stock's closing price of CA$2.60 reflects a significant increase from previous levels, suggesting heightened investor interest.
Bull case
The rise in TelyRx's stock price suggests strong investor confidence, likely fueled by the company surpassing one million prescriptions filled. This achievement highlights its position in the market and could signal further growth ahead.
Bear case
Despite the positive movement, investors should be cautious. TelyRx currently has a negative profit margin and does not offer a dividend yield, which raises questions about its financial sustainability.
Advertisement
Market Reaction to TelyRx's Growth
The 13.04% increase in TelyRx's stock price indicates a strong market reaction to the company's ongoing growth in the digital pharmacy space. Investors are likely encouraged by recent achievements, including the surpassing of one million prescriptions filled, which positions TelyRx favorably in a competitive market.
Financial Considerations for Investors
While the recent surge is promising, potential investors should consider TelyRx's financial metrics. With a negative profit margin and no dividend yield, the company faces challenges that could impact long-term growth. Investors should weigh these factors against the recent positive momentum.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
